AZR Azora Therapeutics, Inc.
3.810USD-21.93%Mkt Cap: 10.00M $P/E: —1d ago
Azora Therapeutics, Inc. operates as a biopharmaceutical company that develops small molecule new chemical entities for the treatment of autoimmune and inflammatory diseases. It offers treatment for dermatology and gastr…
Industry Peers
Biotechnology$141.56BUSDP/E 32.5
$95.53BUSDP/E 22.9
$88.52BUSD
$67.68BUSD
$59.72BUSDP/E 24.9
$56.50BUSDP/E 32.5
$56.15BUSDP/E 30.9
$42.13BUSDP/E 66.2
$41.00BUSD
$38.82BUSDP/E 35.7
$35.82BUSDP/E 48.2
$35.09BUSDP/E 44.9
$26.66BUSD
$24.70BUSD
$24.40BUSDP/E 15.3
$22.15BUSD
$22.10BUSDP/E 27.8
$17.19BUSDP/E 21.9
$16.53BUSDP/E 19.3
$14.86BUSDP/E 38.3
Key Statistics
Company
Market Cap10.00M USD
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)—
Revenue/Share—
Last Price3.810 USD
Fiscal Year End—
MR Quarter—
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B—
EPS (TTM)-20.65
EPS (Forward)—
52W Range
3.03240% of range4.970
52W High4.970 USD
52W Low3.032 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE—
ROA—
ROIC—
ROCE—
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF—
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Net Debt/FCF—
Balance Sheet
Debt/Equity—
Current Ratio—
Quick Ratio—
Book Value/Sh—
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateFeb 6, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.2.63M
Float—
Insiders—
Institutions—
Short Interest
Short Ratio4.3d
Short % Float6.87%
Short % Out.6.84%
Shares Short179.57K
Short (prev mo.)209.98K
Technical
SMA 50—
SMA 200—
Beta—
S&P 52W Chg12.87%
Avg Vol (30d)158.03K
Avg Vol (10d)—
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—